Quantum BioPharma Ltd. Supports Unbuzzd's $5 Million Fundraising Effort
June 26th, 2025 1:25 PM
By: Newsworthy Staff
Quantum BioPharma Ltd. backs Unbuzzd Wellness Inc. in a $5 million raise aimed at expanding the reach of its hangover-reducing beverage, marking a strategic move towards a future IPO.
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company, has announced its support for Unbuzzd Wellness Inc., a portfolio company, in raising up to $5 million through a Regulation D 506(c) offering. Unbuzzd, known for its beverage unbuzzd(TM) designed to accelerate alcohol metabolism and alleviate hangover symptoms, intends to utilize the funds to broaden its distribution channels, including direct-to-consumer, retail, and distributor networks. This fundraising initiative is seen as a pivotal step towards Unbuzzd's anticipated initial public offering (IPO).
The collaboration involves MZ Digital and Dealmaker, with Unbuzzd being led by CEO John Duffy, a former Coca-Cola executive, and advised by Gerry David, the ex-CEO of Celsius Holdings. Quantum BioPharma's involvement underscores its commitment to fostering innovation in the biotech and wellness sectors, particularly in addressing alcohol misuse disorders and metabolic challenges. The company retains a significant stake in Unbuzzd and stands to benefit from royalty payments tied to the sales of unbuzzd(TM), highlighting the strategic nature of this investment.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
